Nachrichten zur Amgen Inc. Aktie

AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF HORIZON THERAPEUTICS

THOUSAND OAKS, Calif., May 16, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement in response to the U.S.…

Why Horizon Therapeutics Stock Is Crashing Today

The FTC is reportedly gearing up to block the drugmakers takeover by Amgen....…

FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC

...(Reuters) - Commissioners at the U.S. Federal Trade Commission......…

Das Beuteschema von Heiko Thieme - New Ökonomie 2.0 durch KI - Vorbereitung auf US-X-DAX mit Leer-Positionen

Die Themen im Heiko Thieme Club: Was ist das Aktien-Beuteschema von Heiko Thieme? Ist der vermeintliche drohende US-Zahlungsausfall, wenn überhaupt,…

Horizon Therapeutics plunges as potential FTC lawsuit increases risk to Amgen deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen: Kommt der Deal mit Horizon zustande? FTC-Abstimmung in dieser Woche - Aktienanalyse

New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Analyst Michael Yee von Jefferies & Co: Michael Yee, Analyst von Jefferies & Co, stuft…

Horizon Shares Slide Premarket on Report That FTC to Fight Amgen Deal

Horizon Shares Slide Premarket on Report That FTC to Fight Amgen Deal...…

Horizon shares sink on report that FTC will sue to block takeover by Amgen

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Horizon Therapeutics tumbles on report FTC preparing suit to block Amgen deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

XFRA : DIVIDEND/INTEREST INFORMATION - 17.05.2023 - US0311621009

Das Instrument AMG US0311621009 AMGEN INC. DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 16.05.2023…

XETR : DIVIDEND/INTEREST INFORMATION - 17.05.2023 - US0311621009

Das Instrument AMG US0311621009 AMGEN INC. DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 16.05.2023…

Horizon Therapeutics ticks higher amid report FTC meeting unrelated to Amgen deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TScan Therapeutics Shares Take Flight on Amgen Pact >TCRX

TScan Therapeutics Shares Take Flight on Amgen Pact >TCRX...…

TScan Therapeutics stock soars after Amgen collaboration on Crohn’s disease treatment that could bring in more than $500 million

Shares of TScan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biopharmaceutical company announced a collaboration…

Amgen, TScan Therapeutics Set Crohns Disease Collaboration

Amgen, TScan Therapeutics Set Crohn's Disease Collaboration...…

Amgen, Entera end research collaboration

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Walgreens Boots, Amgen share losses lead Dows 84-point fall

Walgreens Boots, Amgen share losses lead Dow's 84-point fall...…

Amgen osteoporosis drug Prolia outperforms commonly used therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen: Prolia Shows Greater Fracture Risk Reduction Than With Alendronate In Real-world Study

THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) said new data from a real-world study of nearly half of a million postmenopausal…

Horizon Pharma gains on report about Amgen potential deal close on May 23

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Amgen Stock Was Sickly Today

The companys asset-to-be reported underwhelming first-quarter results....…

AMGEN TO PRESENT AT THE 2023 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., May 3, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 Bank of America Merrill Lynch…

Walgreens Boots, Amgen share losses lead Dows 85-point fall

Walgreens Boots, Amgen share losses lead Dow's 85-point fall...…

Novartis und Sandoz in den USA wegen Patent-Verletzungen verklagt

Pharma - Dem Pharmakonzern Novartis und seiner Generika-Tochter Sandoz droht eine weitere gerichtliche Auseinandersetzung wegen Patentstreitigkeiten in den USA. Gemäss…

Amgen sues Novartis to block generic osteoporosis, bone cancer drugs

...By Blake Brittain (Reuters) - Amgen Inc sued Novartis AGs Sandoz......…

Amgen wird etwas optimistischer

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat seine Erwartungen an das laufende Geschäftsjahr etwas nach oben geschraubt. Beim Umsatz…

Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised

Amgen (AMGN) beats estimates for earnings but misses the same for sales. It raises its earnings and sales guidance for…

Biotech-Riese Amgen wird etwas optimistischer

Biotechnologie - Der US-Biotechkonzern Amgen hat seine Erwartungen an das laufende Geschäftsjahr etwas nach oben geschraubt....…

Amgen 1st quarter profit falls as costs rise, sales flatten

...By Deena Beasley (Reuters) -Amgen Inc on Thursday reported lower......…

UPDATE 1-Amgen 1st quarter profit falls as costs rise, sales flatten

... (Reuters) - Amgen Inc on Thursday reported lower first-quarter profit......…

Amgen wird etwas optimistischer

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat seine Erwartungen an das laufende Geschäftsjahr etwas…

Amgen Inc. Q1 Profit Increases, beats estimates

THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) announced a profit for its first quarter that increased from the same period…

Amgen Raises 2023 Revenue, EPS Outlook

Amgen Raises 2023 Revenue, EPS Outlook...…

Amgen 1Q Net Income Surges Despites 2% Dip in Revenue

Amgen 1Q Net Income Surges Despites 2% Dip in Revenue...…

Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?

Volume growth from Amgens (AMGN) key drugs like Prolia, Repatha and Evenity, among others is expected to have been partially…

AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS

THOUSAND OAKS, Calif., April 21, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial…

Amgen (AMGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Amgen (AMGN) Gains As Market Dips: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $246.21, marking a +0.05% move from the previous day....…

Amgen wins appeal in US patent case over generic psoriasis drugs

...By Blake Brittain (Reuters) - Amgen Inc convinced a U.S. appeals......…

Amgen: Kurszielsenkung

London (www.aktiencheck.de) - Rating-Update: Carter Gould, Analyst von Barclays, stuft die Amgen-Aktie (ISIN: US0311621009, WKN: 867900, Ticker-Symbol: AMG, NASDAQ-Symbol: AMGN)…

Amgen (AMGN) Gains But Lags Market: What You Should Know

Amgen (AMGN) closed the most recent trading day at $251.44, moving +0.78% from the previous trading session....…

Amgen acquisition of Horizon Therapeutics on track to close in 1H - report

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Amgen (AMGN) closed at $253.35 in the latest trading session, marking a -0.01% move from the prior day....…

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Bloom Energy, ConocoPhillips, Livent, Palo Alto Networks, SLM, UnitedHealth and More

Thursdays top analyst upgrades and downgrades included Amgen, Arista Networks, Bloom Energy, ConocoPhillips, Fastenal, Livent, On Holding, Palo Alto Networks,…

dpa-AFX ProFeed